Pyramid Biosciences is a company dedicated to developing targeted therapeutics for a range of disorders regulated by the tropomyosin receptor kinase (TRK) modulators. The aim of the company is to produce medical drugs to treat diseases in oncology and dermatology using the system of key signaling pathways responsible for patients' conditions or symptoms modulating the actions of the fundamental cell surface receptors.